Lv3
250 积分 2023-04-27 加入
Adverse Effects Versus Non-adverse Effects in Toxicology
3天前
已完结
Carbon Nanodots
12天前
已完结
2025 FDA approvals
1个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
1个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
1个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
1个月前
已完结
Off-target Effects of Oligonucleotides and Approaches of Preclinical Assessments
1个月前
已完结
Assessing Hybridization-Dependent Off-Target Risk for Therapeutic Oligonucleotides: Updated Industry Recommendations
1个月前
已完结
The current landscape of nucleic acid therapeutics
1个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
1个月前
已完结
皖公网安备34019202002308
